In the wake of the W.R. Grace indictment for asbestos poisoning in Libby, Mont., Australian building products company James Hardie Industries is working hard to make sure it escapes responsibility for asbestos building products and brake linings it exported to the U.S. from the 1960s to the 1980s.
The company has hired Washington influence peddling firm Shea and Gardner – a subsidiary of Goodwin Proctor – to push its powerful Republican contacts for legislation establishing President Bush’s $140 billion scheme to eliminate asbestos lawsuits.
Hardie’s newfound interest in American politics comes after The Australian broke the story last week of Hardie’s asbestos dealings, plus a secret payout to an American victim from one of Hardie’s former subsidiaries. Just before Christmas, Hardie also agreed to a $1.5 billion (Australian) fund for Australian victims of products it manufactured until 1987.
Unfortunately for Hardie, that will likely not be enough to cover the potential American lawsuits, said Steve Kazan, whose Oakland-based firm has decided to pursue this case. Kazan said, however, that he and his colleagues will be “quite happy” to sue Hardie’s registered U.S. subsidiaries on behalf of the sick and dying when and if the trust fund is exhausted. This move should help to prevent Hardie from hiding behind the Australian government, which the company is lobbying for protection through legislation allowing only Australians to covered by the compensation fund.
For more information on asbestos and industry’s efforts to avoid caring for those it poisoned, please see EWG’s studies A Slow Death in Texas and Asbestos: Think Again.
Related News
Continue Reading
Dirty Dozen™ food chemicals: Potassium bromate
EWG’s recommendation
Avoid or limit foods containing potassium bromate.
Potassium bromate has been classified as a possible carcinogen by the World Health Organization’s cancer research agency, based on...
Study: Hundreds of chemicals linked to breast cancer in lab and animal studies in high use in the U.S.
Breast cancer is the second most common cancer diagnosis among women and cases are on the rise. Anyone can get breast cancer – but it’s most common in women.
A new peer-reviewed study looks at where...
Surging rates of high blood pressure in pregnancy – does chemical exposure play a role?
Rates of high blood pressure during pregnancy have risen sharply, up 73% between 2016 and 2024, according to a report from the Centers for Disease and Control Prevention.
The 2026 report, finding the...
What to know about the new wave of biotech beauty
Cosmetics ingredients once discussed mostly in dermatology clinics, research labs or professional spas are now widely available. And biotechnology, or biotech, for personal care products is a rapidly...